Q3 2022 Holdings
Filed 2022-11-14 | 128 holdings | $725.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $123.6M | 350,000 | 17.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $86.5M | 3,057,869 | 11.9% |
| Align Technology Inc(ALGN) | COM | 016255101 | $71.2M | 344,000 | 9.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $66.6M | 332,500 | 9.2% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $66.1M | 845,000 | 9.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $62.4M | 3,961,249 | 8.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $43.9M | 425,500 | 6.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $22.4M | 264,500 | 3.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $21.6M | 1,712,507 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $21.5M | 443,000 | 3.0% |
| Conmed Corp(CNMD) | COM | 207410101 | $18.7M | 233,000 | 2.6% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $18.4M | 1,015,757 | 2.5% |
| Azenta Inc(AZTA) | COM | 114340102 | $14.2M | 330,200 | 2.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $12.5M | 280,100 | 1.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $12.2M | 5,333,188 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $11.9M | 421,604 | 1.6% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $11.6M | 725,000 | 1.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $11.4M | 403,737 | 1.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $8.0M | 1,066,408 | 1.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $7.1M | 730,846 | 1.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $5.3M | 111,430 | 0.7% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.9M | 223,255 | 0.4% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $2.5M | 2,357,544 | 0.3% |
| Humana Inc(HUM) | COM | 444859102 | $206.9K | 426,500 | 0.0% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $181.4K | 7,747,500 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $164.0K | 3,493,743 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $136.1K | 269,500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $119.2K | 1,122,500 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $118.9K | 518,500 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $117.2K | 3,262,500 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $101.4K | 1,538,195 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $93.1K | 413,762 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $90.3K | 476,000 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $73.1K | 224,315 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $70.6K | 2,499,148 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $60.5K | 866,776 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $56.0K | 298,500 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $54.1K | 1,017,500 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $52.1K | 631,000 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $50.1K | 180,100 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $49.2K | 1,187,992 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $47.5K | 430,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $46.6K | 1,369,973 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $45.0K | 727,000 | 0.0% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $44.4K | 180,500 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $43.1K | 1,760,865 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $41.7K | 1,155,961 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $41.1K | 678,462 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $40.8K | 1,192,400 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $40.7K | 755,500 | 0.0% |